Neursantys
PrivateLast Round
Grant
Jul 27, 2024
Est. Valuation
$3.12M
Total Funding Raised
$842,500
Company Overview
Neursantys is a medical devices company developing non-invasive bioelectronic devices and treatments to address neuromotor conditions caused by aging, trauma, or disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neursantys Comparables
Compare Neursantys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RxFunction | 80% | |
| Bioness Medical, Inc. | 78% | |
| GaitBetter | 74% | |
Neursantys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2024 | ||||
| Grant | Jun 12, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
| Seed | Mar 14, 2023 | ||||
Grant | Jun 30, 2022 |
Neursantys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| a2 Collective | Grant |
| AgeTech Collaborative | Grant |
| mHUB Ventures | Seed, Accelerator |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
| Canadian Space Agency | Grant |
| Edward-Elmhurst Health Venture Capital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 46% MoM.
- Sep 17, 2025
Neursantys won "top honors" in an unspecified category for its pilot study of the NEURVESTA Vestibular Stimulation Therapy.
Neursantys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neursantys's valuation, stock price, and market status.